Trilegal and CMS INDUSLAW advised on OrbiMed’s USD 37 million investment in Iswarya Health.
Iswarya Health, one of India’s leading fertility platforms, has received a primary investment from OrbiMed Asia VI Mauritius, an investment vehicle of OrbiMed, a global healthcare-focused investment firm specialising in life sciences and medical services.
The investment marks Iswarya Fertility Centre’s first institutional capital raise and will support the company’s next phase of growth, including strengthening clinical capabilities, expanding its footprint and enhancing access to high-quality fertility care across India.
Founded in 1987, Iswarya Fertility Centre has grown into a nationwide fertility network with over 87 centres across India and has supported more than 300,000 couples through advanced fertility treatments and reproductive healthcare services.
Trilegal represented Iswarya Health and its promoters in connection with the primary investment by OrbiMed.
The Trilegal Corporate Team advising on the matter was led by Partner Rahul Chugh, and supported by Senior Associate Kriti Chatrath and Associate Samridhi Poddar.
CMS INDUSLAW advised OrbiMed on its USD 37 million investment in Iswarya Fertility Centre.
The CMS INDUSLAW team comprised Founding and Senior Partner Kartik Ganapathy, who provided strategic inputs on certain aspects of the transaction; Partner Aakash Dasgupta, Senior Associates Ravin Abhyankar and Anshul Bhuwalka, and Associate Saumya Joshi, who advised on the transaction; Partner Shantanu Jindel advised on regulatory aspects; Associates Aanshavi Srishti, Abhinav A, Suryanshu Mishra and Samarth Jain assisted with due diligence; Executive Director Ruhi Jain, Manager Praveen Hegde and Assistant Manager Adarsh Joshi advised on corporate secretarial aspects; and Partner Bharadwaj Jaishankar and Senior Associate Trushita Mehra advised on intellectual property aspects.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
